Jane Street Group, LLC Vincerx Pharma, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 20,905 shares of VINC stock, worth $3,971. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,905

Holding current value

$3,971

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$0.51 - $0.84 $10,661 - $17,560	20,905 New	20,905 $15,000
Q1 2024 May 15, 2024	BUY	$1.07 - $8.06 $31,370 - $236,303	29,318 New	29,318 $148,000

Others Institutions Holding VINC

# of Institutions

Shares Held

11M

Call Options Held

Put Options Held

Armistice Capital, LLC New York, NY

2.7M
Shares

$513,760
0.03% of portfolio
Prosight Management, LP Dallas, TX

2.21M
Shares

$419,235
0.43% of portfolio
Sage Rhino Capital LLC

1.7M
Shares

$323,648
0.28% of portfolio
Rock Springs Capital Management LP Baltimore, MD

892K
Shares

$169,426
0.02% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

674K
Shares

$128,096
0.0% of portfolio

View Full List

About Vincerx Pharma, Inc.

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $4.03M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

More about VINC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account